Daxor expands BVA services at Midwest healthcare facility

Daxor (DXR) announces a significant expansion into a leading Midwest healthcare facility. This 735-bed medical campus will integrate Daxor’s blood volume analysis, BVA, testing into its outpatient care, enhancing precision in fluid management and patient outcomes. “Precise volume management is at the heart of effective cardiovascular care, and this expansion continues to widen the ezBVA footprint in the Midwest,” explained Michael Feldschuh, Daxor’s CEO and President. “Our BVA diagnostic provides clinicians with 98% accurate data, enabling personalized fluid management that improves patient outcomes while reducing costs. The ezBVA Lab service offers healthcare facilities access to our BVA technology without requiring capital expenditure. This service is fully reimbursable through established CPT codes for both inpatient and outpatient settings under public and private insurance plans.”